VNRX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
398.7K
-59.5%
985.1K
+120.4%
447.0K
-28.7%
627.3K
+54.2%
406.7K
Cost of Revenue
0
0
0
0
0
Gross Profit
398.7K
-59.5%
985.1K
+120.4%
447.0K
-28.7%
627.3K
+54.2%
406.7K
Operating Expenses
4.6M
-28.1%
6.3M
+20.3%
5.3M
-8.1%
5.7M
-14.6%
6.7M
R&D
1.8M
-36.9%
2.9M
+15.6%
2.5M
+8.0%
2.3M
-16.0%
2.7M
SG&A
2.8M
-20.9%
3.5M
+24.5%
2.8M
-18.7%
3.4M
-13.6%
4.0M
Operating Income
-4155983
+22.3%
-5348852
-11.0%
-4818384
+5.5%
-5100990
+19.0%
-6297807
EBITDA
-4155983
+19.2%
-5141481
-12.1%
-4587560
+5.5%
-4852737
+22.9%
-6297807
Net Income
-7315263
-9.1%
-6703557
-6.4%
-6302841
-16.5%
-5409791
+14.3%
-6314070
EPS (Basic)
$-0.85
+12.4%
$-0.97
-64.4%
$-0.59
+41.0%
$-1.00
+18.0%
$-1.22
EPS (Diluted)
$-0.85
+12.4%
$-0.97
-64.4%
$-0.59
+41.0%
$-1.00
+18.0%
$-1.22
Shares (Diluted)
9.2M
+33.0%
6.9M
-35.0%
10.6M
+95.6%
5.4M
+5.4%
5.1M
VolitionRx (VNRX) โ€” Financials